The LNCaP-CRPC cells have also acquired some phenotypic CSC markers including CD44, α2β1, and ABCG2, all of which have been shown by us to enrich for tumor-initiating and tumor-propagating cells in different PCa models [2, 3, 28-30]. The gene discussed is CD44; the disease is posterior cortical atrophy.